IRVINE, Calif., June 26 (HSMN NewsFeed) — ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ) today announced the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the U.S. Food and Drug Administration (FDA) recommended the approval of Bepreve(TM…
Biopharmaceuticals, Ophthalmology
ISTA Pharmaceuticals, Bepreve, bepotastine

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Dermatologic and Ophthalmic Drugs Advisory Committee Unanimously Recommends Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis”
Leave a Comment